FAQ/Help |
Calendar |
Search |
Today's Posts |
08-26-2013, 07:44 PM | #1 | |||
|
||||
Senior Member
|
Dr. David Healy, has started a petition to get AbbVie and InterMune to drop their legal action to block access to European Medicines Agency (the european equivalent to US FDA) clinical trial data.please consider supporting this petition.
Here's the link - http://chn.ge/14VbZyT
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
"Thanks for this!" says: | soccertese (08-26-2013), Tupelo3 (08-26-2013) |
08-26-2013, 11:23 PM | #2 | ||
|
|||
Junior Member
|
Curiously, my husband is in Abbvie's Duodopa study and has been for 2+ years. With FDA approval right around the corner, it appears that their goal is making their statistics look good not only to the FDA, but Medicare and private insurance agencies. Patient care for their guinea pigs in not necessarily their first priority. As I understand it, and I could be completely wrong, in the Phase I clinical trial there were only 65 patients nationwide. I mean, how can you draw any conclusions from that small sampling of people?
|
||
Reply With Quote |
08-27-2013, 07:16 AM | #3 | |||
|
||||
Senior Member
|
Hi Parkiwife, First Thank your husband for participating in this clinical trial. If Duodopa becomes licensed in the US, it will be in large part due to his efforts.
Usually, Phase 1 studies involve a very small number of individuals. Phase 1 studies are to show safety of the drug (though this drug formulation has been used in Europe for many years now and why those trial data cannot be utilized by the US, I have no insight.) The explanation of the phases of drug study are below--note the phase 4 which the FDA usually recommends after okaying a drug and is never ever done as far as i can discern. " Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will normally proceed through all four phases over many years. If the drug successfully passes through Phases 0, 1, 2, and 3, it will usually be approved by the national regulatory authority for use in the general population. Phase 0: Pharmacodynamics and Pharmacokinetics Phase 1: Screening for safety Phase 2: Establishing the efficacy of the drug, usually against a placebo Phase 3: Final confirmation of safety and efficacy Phase 4: Sentry studies during sales" http://en.wikipedia.org/wiki/Clinical_trial
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
"Thanks for this!" says: | Tupelo3 (08-27-2013) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
May2009: Ceregene Presents Additional Clinical Data Phase 2 Trial of CERE-120 for PD | Parkinson's Disease | |||
CERE-120 /May2009/ Clinical Data from Phase 2 Trial of CERE-120 for PD | Parkinson's Disease Clinical Trials | |||
CLINICAL TRIAL...Phase III Trial with Pimavanserin in Patients with PD Psychosis | Parkinson's Disease Clinical Trials |